Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
/in Brain Tumors in Children, Checkpoint-Inhibitors, Glioblastoma, International PublicationsDevelopment of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
/in Brain Tumors in Children, International Publications, IOZK VeröffentlichungenImmunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
/in Brain Tumors in Children, Dendritic Cells, International PublicationsImmunotherapy of Brain Tumors
/in Brain Tumors in Children, Dendritic Cells, International PublicationsDiffuse intrinsic pontine glioma: time for therapeutic optimism
/in Brain Tumors in Children, International PublicationsAutologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas
/in Brain Tumors in Children, Dendritic Cells, International PublicationsAdjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenCombined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid
/in Brain Tumors in Children, Glioblastoma, International Publications, Newcastle Disease VirusTransient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report
/in Brain Tumors in Children, Dendritic Cells, Glioblastoma, International Publications, IOZK VeröffentlichungenIMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de